BSE filing, NSE: BERLDRG. Summary written from the filing by ALFA Finder's alert engine.
Beryl Drugs Ltd: key numbers
- Share price
- ₹25.60
- Market cap
- ₹12.98 Cr
- Revenue (annual)
- ₹18.82 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 20.8×Sector 45.9×
- Promoter holding
- 27.97%+0.15% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Beryl Drugs Ltd
All →Beryl Drugs Other Announcement
Beryl Drugs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Beryl Drugs Other Announcement
Beryl Drugs Limited has submitted its quarterly compliance certificates regarding Regulation 74(5) and a non-applicability confirmation for Regulation 57(5) for the quarter ended September 30, 2026.
Beryl Drugs Annual General Meeting
Beryl Drugs Limited held its 33rd Annual General Meeting on September 29, 2026. Shareholders approved audited financial statements, director reappointment, and increased related-party transaction limits.
Beryl Drugs Annual Report
Beryl Drugs Ltd has submitted its 33rd Annual Report for the financial year 2025-26, scheduled for its upcoming Annual General Meeting.
Beryl Drugs Annual General Meeting
Beryl Drugs Ltd has announced the closure of its register of members from September 23 to September 29, 2026, for its 33rd Annual General Meeting.
Beryl Drugs Board Meeting Outcome
Beryl Drugs Limited approved items for its 33rd Annual General Meeting and a proposal to increase material related party transaction limits.
Other adverse business impact announcements
All →Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr
Hindustan Organic Chemicals Adverse Business Impact
Hindustan Organic Chemicals temporarily shuts down its Kochi Hydrogen plant from 29 October 2026 for pipeline repair and urgent maintenance. Reopening date to be communicated separately.
IIFL Capital Services Adverse Business Impact
IIFL Capital Services' subsidiary surrendered its SEBI Investment Adviser registration, effective October 28, 2026. The company states there is no material monetary impact and no penalty.
Ecoboard Industries Adverse Business Impact
Ecoboard suspended its Particle Board division for one year over raw material shortages and non-viability. Venkatraman Krishnamurthi was appointed CEO, while Gottumukkala steps down to MD.
- Execution
- One (1) year temporary suspension
Latteys Industries Adverse Business Impact
Latteys Industries reported a suspected Boss Scam cyber fraud causing an unauthorised ₹0.8 Crore transfer. No recovery yet; financial impact under assessment.
- Value
- ₹0.80 Cr